Druckers has been at the forefront of GLP-1 research since the 1980s when his pioneering discoveries helped lay the groundwork for the development of GLP-1 medicines
Disease Primers, 1, 15018
This article discusses the mechanisms of action and efficacy of these agents, highlighting recent advances such as polyagonists and oral formulations
For many people with RA, managing these symptoms is a daily battle, requiring a combination of medication, lifestyle adjustments, and sometimes physical therapy
Dr Fatma Al Kaabi, Director General of the EDE, said the approval reflects the authoritys commitment to strengthening the pharmaceutical ecosystem and addressing obesity as a key driver of chronic disease while supporting the evaluation of innovative therapies in line with international scientific standards